FAMILIAL CANCER CLINIC

NATIONAL RESEARCH

Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study

Gupta S, Rajappa S, Advani S, Agarwal A, Aggarwal S, Goswami C, Palanki SD, Arya D, Patil S, Kodagali R

BRCA1 and BRCA2 mutations in ovarian cancer


Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Agarwal A, Sarin R, Ahmed R, Almel S, Chakraborti Bm et al.

Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening

Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A. et al.

Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India

Mannan, A., Singh, J., Lakshmikeshava, R. et al.

Molecular genetics analysis of hereditary breast and ovarian cancer patients in India

Soumittra N, Meenakumari B, Parija T, Sridevi V, Nancy KN, Swaminathan R, Rajalekshmy KR, Majhi U, Rajkumar T, et al

Spectrum of germline BRCA mutations in hereditary breast and ovarian cancer syndrome in Indian population

Chedda P, Pande S, Dama T, Vinarkar S, Chanekar M, Limaye S, et al

Genetic testing for hereditary breast and ovarian cancer in Indian population: A single institutional study.

Veda Padma Priya Selvakumar, Shubha Garg, Jatinder Kaur, Geeta Kadayaprath,  et al

Mutations in BRCA1/2 genes Unexpected higher prevalence in Indian Patients

Verma, Amit; Julka, Pramod Kumar; Kaur, Jatinder, et al